Post
Investors anticipate “bounce-back” in European private investment
The Swiss biotech ecosystem suffers from a “weak public market”, said Francesco de Rubertis, a cofounder at Medicxi Ventures. Despite …
Novartis bags paediatric FDA label expansion for Lutathera
Novartis has received a US Food and Drug Administration (FDA) approval for the label expansion of its peptide receptor radionuclide …
Johnson & Johnson gets grant for heart ultrasound image selection based on physiological cycle
Johnson & Johnson's patented method involves using ultrasound frames to assess heart function. The system processes signals tracking physiological cycles …
Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcma
Pfizer has patented CARs that target BCMA for treating conditions related to malignant cells expressing BCMA, like cancer. The method …
Bicycle Therapeutics gets grant for high affinity binders of nectin-4 for treating diseases
Bicycle Therapeutics has been granted a patent for polypeptides covalently bound to molecular scaffolds, specifically high affinity binders of Nectin-4. …
Viatris gets grant for nasal spray method for treating dry eye disease
Viatris has been granted a patent for methods and pharmaceutical formulations to treat dry eye disease. The patent involves administering …
Sanofi gets grant for optical decoding system for determining medicament dose in drug delivery device
Sanofi has been granted a patent for an optical decoding system that uses an optical sensor to capture images of …
Apellis Pharmaceuticals gets grant for treatment of complement-mediated eye disorder with long-acting compstatin analog
Apellis Pharmaceuticals has been granted a patent for cell-reactive compstatin analogs to treat complement-mediated disorders. The method involves administering long-acting …
Ipsen gets grant for treatment of diseases with specific benzothiazepine and benzothiadiazepine derivatives
Ipsen has been granted a patent for certain 1,5-benzothiazepine and 1,2,5-benzothiadiazepine derivatives as bile acid modulators with potential in treating …
Seres Therapeutics gets grant for composition of isolated bacteria in capsule for dysbiosis treatment
Seres Therapeutics has been granted a patent for a composition containing specific bacterial species encapsulated in a capsule, aimed at …
BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment
BioCryst Pharmaceuticals has been granted a patent for compounds that inhibit the complement system, potentially treating diseases with abnormal complement …
MacroGenics gets grant for patent granted for compounds targeting IL23a and BAFF
MacroGenics has been granted a patent for compounds targeting IL23A and BAFF, with methods for suppressing inflammatory responses. The patent …
Astellas Pharma gets grant for antibodies for diagnosing cancer by detecting cldn6 expression
Astellas Pharma has been granted a patent for antibodies targeting CLDN6, aiding in cancer diagnosis and determining CLDN6 expression in …
Spectrum Pharmaceuticals gets grant for crystalline form of quinazoline compound and hydrochloride salts
Spectrum Pharmaceuticals has been granted a patent for the crystalline forms of a quinazoline compound and its hydrochloride salts. The …
Revance Therapeutics gets grant for stabilized botulinum toxin formulation without protein excipients
Revance Therapeutics has patented a botulinum toxin formulation without proteinaceous excipients. The pharmaceutical composition includes non-peptide excipients like surfactants, sugars, …